GT Biopharma Ownership
Who are the major shareholders and have insiders been buying or selling?
Recent Insider Transactions
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Ownership Breakdown
Owner Type | Number of Shares | Ownership Percentage |
---|---|---|
Private Companies | 659 | 0.0464% |
Individual Insiders | 51,963 | 3.66% |
Hedge Funds | 72,512 | 5.11% |
Public Companies | 91,860 | 6.47% |
Institutions | 1,202,997 | 84.7% |
Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 12.5%.
Top Shareholders
Ownership | Name | Shares | Current Value | Change % | Portfolio % | |
---|---|---|---|---|---|---|
1,093,645 | €3.1m | 0% | no data | |||
91,860 | €258.6k | 0% | no data | |||
72,512 | €204.1k | 0% | 0.01% | |||
36,266 | €102.1k | 0.07% | no data | |||
28,541 | €80.3k | 0% | no data | |||
19,874 | €55.9k | 0% | no data | |||
11,755 | €33.1k | 0% | no data | |||
11,667 | €32.8k | 0% | no data | |||
11,243 | €31.7k | 0% | no data | |||
10,134 | €28.5k | 0% | no data | |||
10,013 | €28.2k | 0% | no data | |||
3,823 | €10.8k | 72% | no data | |||
3,290 | €9.3k | 11.3% | no data | |||
2,665 | €7.5k | 0% | no data | |||
2,198 | €6.2k | -25.1% | no data | |||
1,926 | €5.4k | 0% | no data | |||
1,239 | €3.5k | 20.2% | no data | |||
1,143 | €3.2k | 0% | no data | |||
1,126 | €3.2k | 0% | no data | |||
1,078 | €3.0k | 0% | no data | |||
762 | €2.1k | 120% | no data | |||
666 | €1.9k | 0% | no data | |||
659 | €1.9k | -1.79% | no data | |||
646 | €1.8k | 0% | no data | |||
486 | €1.4k | 67% | no data |